(Q34500544)
Statements
The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma (English)
Andrew Spencer
Sung-Soo Yoon
Shannon R Morris
Deborah A Smith
Richard A Brigandi
Jennifer Gauvin
Rakesh Kumar
Joanna B Opalinska
1 reference